A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.
Cystic Fibrosis
COVID-19: New safety measures and visitor guidelines, testing locations & family resources
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.